Table 3 Efficacy and safety outcomes in patients who were enrolled in the first month after ACS compared to those who were enrolled from the second to the sixth months after ACS
First month | Second to sixth months | P value | |
|---|---|---|---|
Percentage | 45.8 | 54.2 | |
Composite primary endpoints (%) | 2.5 | 1.8 | 0.548 |
Secondary efficacy endpoints (%) | 10.8 | 7.6 | 0.168 |
Cardiovascular death (%) | 0.7 | 0.9 | 0.802 |
Myocardial infarction (%) | 0.7 | 1.5 | 0.360 |
Stroke (%) | 2.5 | 0.6 | 0.051 |
Hospitalization for UA (%) | 7.9 | 6.4 | 0.458 |
Urgent revascularization (%) | 4.3 | 3.9 | 0.786 |
TIMI major bleeding (%) | 1.1 | 1.5 | 0.641 |
TIMI minor bleeding (%) | 13.7 | 11.5 | 0.406 |
Intracranial hemorrhage (%) | 0.4 | 0.3 | 0.899 |
Dyspnea (%) | 11.5 | 9.4 | 0.394 |
Bradycardia (%) | 4 | 3.6 | 0.831 |